Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 45,020 $ 8,983
Short-term investments 9,494 0
Contracts receivable and retainage, net 28,933 28,466
Contracts in progress 40,187 28,373
Inventory 6,568 4,933
Prepaid expenses and other assets 3,456 3,833
Assets held for sale 42,670 104,576
Total current assets 176,328 179,164
Property, plant and equipment, net 80,707 88,899
Other noncurrent assets 5,922 2,777
Total assets 262,957 270,840
Current liabilities:    
Accounts payable 20,166 18,375
Advance billings on contracts 14,930 5,136
Deferred revenue 829 4,676
Accrued contract losses 6,033 7,618
Accrued expenses and other liabilities 10,339 12,860
Total current liabilities 52,297 48,665
Deferred revenue, noncurrent 2,489 769
Other noncurrent liabilities 3,035 1,913
Total liabilities 57,821 51,347
Shareholders’ equity:    
Preferred stock, no par value, 5,000 shares authorized, no shares issued and outstanding 0 0
Common stock, no par value, 20,000 shares authorized, 15,044 shares issued and outstanding at September 30, 2018 and 14,910 at December 31, 2017 10,957 10,823
Additional paid-in capital 101,661 100,456
Retained earnings 92,518 108,214
Total shareholders’ equity 205,136 219,493
Total liabilities and shareholders’ equity $ 262,957 $ 270,840